Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]

Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite] Publisher Pubmed

Shadnoush M¹ ; Rabizadeh S² ; Esteghamati A² ; Nakhjavani M² ; Paridari NB³ ; Khoshabi M⁴ ; Rajab A² ; Ghaemi F⁵

Source: Eastern Mediterranean Health Journal Published:2022

Abstract

Background: Diabetes mellitus and hypertension are highly prevalent among patients with severe COVID-19. Aims: To study the mortality risk of COVID-19 infection in patients with type 2 diabetes and additive effect of hypertension and obesity in the Iranian population. Methods: This was a cross-sectional survey of the national COVID-19 registry from the Iranian Ministry of Health. The medical status of 22 002 patients with COVID-19 between 1 March and 30 April 2020 was analysed. Results: Patients with type 2 diabetes had a higher risk of mortality with an odds ratio (OR) of 1.67 [95% confidence interval (CI): 1.53–1.82, P < 0.001]. The risk of mortality was also high in patients with diabetes and hypertension, with an odds ratio of 1.76 (95% CI: 1.56–1.99, P < 0.001). The odds ratio of the risk of mortality in patients with diabetes, hypertension and obesity was 1.87 (95% CI: 1.35–2.58, P < 0.001). Conclusion: Type 2 diabetes, hypertension and obesity each predict mortality in Iranian patients with COVID-19, and when they are present together, patients have a greater risk of mortality. © World Health Organization (WHO) 2022.

Related Docs

View other Related Docs

1. Factors Associated With Mortality in Covid-19 Patients: A Systematic Review and Meta-Analysis, Iranian Journal of Public Health (2020)

2. Metabolic Syndrome and Covid-19; Clinical Complications and Challenges, Journal of Isfahan Medical School (2021)

3. Examining the Prevalence of Covid-19 Patients With Diabetes and the Relationship Between the Two Diseases in Ghaem Hospital, Mashhad, Journal of Medicinal and Pharmaceutical Chemistry Research (2024)

Experts (# of related papers)

View all Related Experts

Bagher Larijani (3)

Samira Kafan (2)

Style	Citing Format
MLA	Shadnoush M, et al.. "Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]." Eastern Mediterranean Health Journal, vol. 28, no. 3, 2022, pp. 221-224.
APA	Shadnoush M, Rabizadeh S, Esteghamati A, Nakhjavani M, Paridari NB, Khoshabi M, Rajab A, Ghaemi F (2022). Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]. Eastern Mediterranean Health Journal, 28(3), 221-224.
Chicago	Shadnoush M, Rabizadeh S, Esteghamati A, Nakhjavani M, Paridari NB, Khoshabi M, Rajab A, Ghaemi F. "Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]." Eastern Mediterranean Health Journal 28, no. 3 (2022): 221-224.
Harvard	Shadnoush M et al. (2022) 'Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]', Eastern Mediterranean Health Journal, 28(3), pp. 221-224.
Vancouver	Shadnoush M, Rabizadeh S, Esteghamati A, Nakhjavani M, Paridari NB, Khoshabi M, et al.. Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]. Eastern Mediterranean Health Journal. 2022;28(3):221-224.
BibTex	@article{ author = {Shadnoush M and Rabizadeh S and Esteghamati A and Nakhjavani M and Paridari NB and Khoshabi M and Rajab A and Ghaemi F}, title = {Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]}, journal = {Eastern Mediterranean Health Journal}, volume = {28}, number = {3}, pages = {221-224}, year = {2022} }
RIS	TY - JOUR AU - Shadnoush M AU - Rabizadeh S AU - Esteghamati A AU - Nakhjavani M AU - Paridari NB AU - Khoshabi M AU - Rajab A AU - Ghaemi F TI - Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite] JO - Eastern Mediterranean Health Journal VL - 28 IS - 3 SP - 221 EP - 224 PY - 2022 ER -

Style

Citing Format

MLA

Shadnoush M, et al.. "Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]." Eastern Mediterranean Health Journal, vol. 28, no. 3, 2022, pp. 221-224.

APA

Shadnoush M, Rabizadeh S, Esteghamati A, Nakhjavani M, Paridari NB, Khoshabi M, Rajab A, Ghaemi F (2022). Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]. Eastern Mediterranean Health Journal, 28(3), 221-224.

Chicago

Shadnoush M, Rabizadeh S, Esteghamati A, Nakhjavani M, Paridari NB, Khoshabi M, Rajab A, Ghaemi F. "Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]." Eastern Mediterranean Health Journal 28, no. 3 (2022): 221-224.

Harvard

Shadnoush M et al. (2022) 'Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]', Eastern Mediterranean Health Journal, 28(3), pp. 221-224.

Vancouver

Shadnoush M, Rabizadeh S, Esteghamati A, Nakhjavani M, Paridari NB, Khoshabi M, et al.. Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]. Eastern Mediterranean Health Journal. 2022;28(3):221-224.

BibTex

@article{ author = {Shadnoush M and Rabizadeh S and Esteghamati A and Nakhjavani M and Paridari NB and Khoshabi M and Rajab A and Ghaemi F}, title = {Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]}, journal = {Eastern Mediterranean Health Journal}, volume = {28}, number = {3}, pages = {221-224}, year = {2022} }

RIS

TY - JOUR
AU - Shadnoush M
AU - Rabizadeh S
AU - Esteghamati A
AU - Nakhjavani M
AU - Paridari NB
AU - Khoshabi M
AU - Rajab A
AU - Ghaemi F
TI - Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite]
JO - Eastern Mediterranean Health Journal
VL - 28
IS - 3
SP - 221
EP - 224
PY - 2022
ER -

Science Communicator Platform

Authors

Abstract